SIREN : 818172991
EUFLORICK is a French company founded 10 years ago, specialized in the sector Activités des sièges sociaux. Based in LUMBRES (62380), this company of category PME shows in 2020 a revenue of 393 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-04-25
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2020 | 2018 | 2016 |
|---|---|---|---|
| Revenue | 393 062 € | N/C | 9 211 € |
| Net income | 14 591 € | -26 024 € | -14 906 € |
| EBITDA | 19 764 € | N/C | -14 665 € |
| Net margin | 3.7% | N/C | -161.8% |
In 2020, EUFLORICK achieves revenue of 393 k€. Over the period 2016-2020, the company shows strong growth with a CAGR (compound annual growth rate) of +155.6%. After deducting consumption (31 k€), gross margin stands at 362 k€, i.e. a rate of 92%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 20 k€, representing 5.0% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 15 k€, i.e. 3.7% of revenue. This profit can be retained or distributed to shareholders.
393 062 €
362 278 €
19 764 €
15 416 €
14 591 €
5.0%
The debt ratio (= Financial debt / Equity x 100) stands at 16%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 77%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 12.3 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high. Cash flow represents 4.8% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
16.203%
76.733%
4.845%
12.29
33.4%
In 2020, the debt ratio of EUFLORICK (16.20) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2020, the financial autonomy of EUFLORICK (76.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2020, the repayment capacity of EUFLORICK (12.29) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 96.75. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
96.747
0.0
In 2020, the liquidity ratio of EUFLORICK (96.75) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2020, the interest coverage of EUFLORICK (0.0x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 90 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 113 days. Favorable situation: supplier credit is longer than customer credit by 23 days. Overall, WCR represents 52 days of revenue, i.e. 57 k€ to permanently finance. Notable WCR improvement over the period (-37%), freeing up cash.
56 770 €
90 j
113 j
0 j
52 j
Based on 83 transactions of similar company sales
in 2020,
the value of EUFLORICK is estimated at
112 852 €
(range 47 792€ - 217 939€).
With an EBITDA of 19 764€, the sector multiple of 4.6x is applied.
The price/revenue ratio is 0.35x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 83 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare EUFLORICK with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sièges sociaux
The revenue of EUFLORICK in 2020 is 393 k€.
Yes, EUFLORICK generated a net profit of 15 k€ in 2020.
The headquarters of EUFLORICK is located in LUMBRES (62380), in the department Pas-de-Calais.
The tax return of EUFLORICK is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
EUFLORICK operates in the sector Activités des sièges sociaux (NAF code 70.10Z). See the 'Sector positioning' section above to compare the company with its competitors.